| 2023 | RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2023 | Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045 | INTERNATIONAL JOURNAL OF CANCER |
| 2022 | RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVAL | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2019 | Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) | GYNECOLOGIC ONCOLOGY |
| 2019 | Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study
| JOURNAL OF CLINICAL MEDICINE |
| 2022 | Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: A multicenter study in Korea | GYNECOLOGIC ONCOLOGY |
| 2020 | Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)
| CANCERS |
| 2020 | Recommendations for gynecologic cancer care during the COVID-19 pandemic
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2020 | Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy
| JOURNAL OF CLINICAL MEDICINE |
| 2022 | ROBOTIC-ASSISTED RADICAL VAGINAL TRACHELECTOMY | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2023 | Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2017 | Role of preoperative magnetic resonance imaging and histological assessment in identifying patients with a low risk of endometrial cancer: a Korean Gynecologic Oncology Group ancillary study
| ONCOTARGET |
| 2017 | Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery
| ONCOTARGET |
| 2015 | Safety of fertility-sparing surgery in primary mucinous carcinoma of the ovary
| CANCER RESEARCH AND TREATMENT |
| 2022 | Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study | GYNECOLOGIC ONCOLOGY |
| 2023 | Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer
| GLAND SURGERY |
| 2023 | Sentinel lymph node biopsy in endometrial cancer: The new norm - A multicentre, international experience | SURGICAL ONCOLOGY-OXFORD |
| 2017 | Sentinel lymph node mapping with indocyanine green in vaginal cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2024 | Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer | CANCER RESEARCH |
| 2023 | Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC)
| BMC CANCER |
| 2017 | Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2017 | Surgical technique for single-port laparoscopy in huge ovarian tumors: SW Kim's technique and comparison to laparotomy
| Obstetrics & Gynecology Science |
| 2020 | Survival outcomes of single-port access laparoscopic radical hysterectomy for early-stage cervical cancer | SURGICAL ONCOLOGY-OXFORD |
| 2024 | The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2017 | The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy | JOURNAL OF SURGICAL ONCOLOGY |
| 2020 | The institutional learning curve is associated with survival outcomes of robotic radical hysterectomy for early-stage cervical cancer-a retrospective study
| BMC CANCER |
| 2021 | Time for enhancing government-led primary prevention of cervical cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2018 | Transcatheter Arterial Embolization for Severe Secondary Hemorrhage after Hysterectomy | JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY |
| 2017 | Treatment Preferences for Routine Lymphadenectomy Versus No Lymphadenectomy in Early-Stage Endometrial Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2016 | Treatment preferences of advanced ovarian cancer patients for adding bevacizumab to first-line therapy | GYNECOLOGIC ONCOLOGY |
| 2016 | Treatment strategies for stage IB cervical cancer: A cost-effectiveness analysis from Korean, Canadian and U.S. perspectives. | GYNECOLOGIC ONCOLOGY |
| 2023 | Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
| NATURE COMMUNICATIONS |
| 2018 | Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure | SURGICAL ONCOLOGY-OXFORD |
| 2017 | Upregulation of homeobox gene is correlated with poor survival outcomes in cervical cancer
| ONCOTARGET |
| 2022 | Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity? | GYNECOLOGIC ONCOLOGY |
| 2022 | USEFULNESS OF PRE-OPERATIVE PET-CT IN PATIENTS WITH ENDOMETRIAL CANCER UNDERGOING SENTINEL LYMPH NODE MAPPING: DO NEGATIVE FINDINGS ON PET-CT NEGATIVITY REALLY INDICATE NODE NEGATIVITY? | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2018 | Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer
| BMC CANCER |
